Indication
Group B Streptococcus pelvic inflammatory disease
Group B Streptococcus pelvic inflammatory disease is an upper female genital tract infection caused by the ascending spread of *Streptococcus agalactiae* (Group B Streptococcus) from the lower reproductive tract. Read more about Group B Streptococcus pelvic inflammatory disease
13 drugs 13 manufacturers
Drugs that treat it
Common Group B Streptococcus pelvic inflammatory disease therapies.
CEFOXITIN (cefoxitin sodium)
CEFOXITIN (cefoxitin sodium)
CEFOXITIN (cefoxitin sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGroup B Streptococcus pelvic inflammatory disease is an upper female genital tract infection caused by the ascending spread of *Streptococcus agalactiae* (Group B Streptococcus) from the lower reproductive tract.
Primarily affecting women of reproductive age, this clinical state encompasses inflammation involving the endometrium, fallopian tubes, ovaries, or adjacent pelvic structures.
Pathophysiologically, the organism disrupts mucosal defenses to induce acute local tissue inflammation, which can progress to endometritis, salpingitis, pelvic peritonitis, or tubo-ovarian abscesses.
Typical clinical features include lower abdominal and pelvic pain, cervical motion tenderness, uterine or adnexal tenderness, purulent cervical discharge, and systemic manifestations such as fever.
- nih.gov
Group B Streptococcus pelvic inflammatory disease is an upper female genital tract infection caused by the ascending spread of *Streptococcus agalactiae* (Group B Streptococcus) from the lower reproductive tract Primarily affecting women of reproductive age, this clinical state encompasses inflammation involving the endometrium, fallopian tubes, ovaries, or adjacent pelvic structures Pathophysiologically, the organism disrupts mucosal defenses to induce acute local tissue inflammation, which can...
- who.int
Group B Streptococcus pelvic inflammatory disease is an upper female genital tract infection caused by the ascending spread of *Streptococcus agalactiae* (Group B Streptococcus) from the lower reproductive tract
- stlouischildrens.org
Primarily affecting women of reproductive age, this clinical state encompasses inflammation involving the endometrium, fallopian tubes, ovaries, or adjacent pelvic structures Pathophysiologically, the organism disrupts mucosal defenses to induce acute local tissue inflammation, which can progress to endometritis, salpingitis, pelvic peritonitis, or tubo-ovarian abscesses Typical clinical features include lower abdominal and pelvic pain, cervical motion tenderness, uterine or adnexal tenderness, ...
- mayoclinic.org
Typical clinical features include lower abdominal and pelvic pain, cervical motion tenderness, uterine or adnexal tenderness, purulent cervical discharge, and systemic manifestations such as fever
Personalize your experience
Follow Group B Streptococcus pelvic inflammatory disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.